Skip to main content
Premium Trial:

Request an Annual Quote

David King, James Henson, Patricia Forbes

David King Joins Quaker BioVentures
Quaker BioVentures has hired David King as a venture partner.
King has served as CEO of three venture-backed life science companies and led them to acquisitions by large pharmaceutical companies.
King was a founder and CEO of BioRexis Pharmaceutical, which was acquired by Pfizer in 2007. Previously, he served as the CEO of Principia Pharmaceutical Corporation, which was acquired by Human Genome Sciences. Prior to that, he was president of Delsys Pharmaceutical, which was acquired by Elan.
King also previously served as a director of Cephalon, 3-Dimensional Pharmaceuticals, and Morphotek.
He is currently a consultant to biotechnology companies and serves as chairman of Xencor.

UN Reno’s Henson Tapped to Help DoD Select Research Projects
The Nevada System of Higher Education Research Affairs Council has selected James Henson, associate chair of the University of Nevada, Reno’s electrical and biomedical engineering department, as the project director for a federally funded research program.
Henson will lead the Department of Defense Experimental Program to Stimulate Competitive Research, or DEPSCoR, a program intended to increase research competitiveness in states that historically have not received significant R&D funding from DoD agencies.
Nevada is one of 25 states and two territories authorized to participate in the program.
According to NSHE, Nevada DEPSCoR programs have totaled more than $4 million and the state has matched more than $2 million in research funding.

Patricia Forbes Joins Relocation Management Firm DPM
Diversified Project Management, a consulting firm that specializes in corporate relocations, has hired Patricia Forbes as project executive.
DPM is an owners' representative firm and provides programming, project management, construction administration, furniture coordination, and move-planning services.
Forbes will work from DPM's headquarters in Newton, Mass.
Prior to joining DPM, she was vice president of development services for Paradigm Properties in Boston. She also worked as project director for the Artery Business Committee and served as vice president of real estate for ChildrenFirst.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.